In our previous articles, we reported that the Federal Circuit affirmed the district court’s decision on December 20, 2024 ...

NEW YORK CITY, NY / ACCESS Newswire / March 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

On July 24, 2024, an activist investor named ManBear published a report titled "Pipe Price Fixing" which accused Atkore and three of its competitors of using the commodity pricing service OPIS to ...

Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the ...

The US shift toward steep tariffs will likely make drugs more expensive and limit access for patients, according to one of ...

As the brisk winds of winter fade and the gentle warmth of spring approaches, the fashion world is bursting with anticipation ...

Corcept's new drug, relacorilant, shows promise with positive Phase 3 results and an FDA decision expected. Learn more about ...

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version ...

Generic drugmakers could be significantly impacted by President Trump's decision to double the tariff on Chinese goods to 20% ...